Advent Pharma Market Cap

Advent Pharma has a market cap or net worth of 1.23 billion as of March 6, 2026. Its market cap has decreased by -16.46% in one year.

Market Cap

1.23B

Enterprise Value

1.30B

Revenue

516.48M

Ranking

n/a

PE Ratio

21.34

Stock Price

13.20

Market Cap Chart

Since April 12, 2018, Advent Pharma's market cap has decreased from 3.32B to 1.23B, a decrease of -62.97%. That is a compound annual growth rate of -11.82%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	1.23B	-0.75%
Dec 30, 2025	1.24B	-20.36%
Dec 30, 2024	1.56B	-32.93%
Dec 28, 2023	2.32B	-1.97%
Dec 29, 2022	2.37B	-0.74%
Dec 30, 2021	2.38B	14.47%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Silva Pharmaceuticals	1.28B
Silco Pharmaceuticals	1.35B
Libra Infusions	1.41B
Central Pharmaceuticals	1.02B
Indo-Bangla Pharmaceuticals	1.52B
Pharma Aids	1.69B
Ambee Pharmaceuticals	1.79B
Techno Drugs	3.87B

Market Cap Rankings